Drug updates !

on 19.1.08 with 0 comments



New drugs and new indications of already approved drugs by FDA in 2006-07


Aliskiren:
  • New class of Renin Inhibitors
  • Once daily oral formulation
  • Mono therapy or in combination with other drugs for treatment of high B.P
Inhaled Insulin:
  • Management of type I and type II Diabetes Mellitus
Cinacalcet:
  • Treatment of secondary hyperparathyroidism in patients with end stage renal disease on maintenance dialysis therapy.
Posaconazole:
  • Triazole antifungal Agent
  • Prevention of invasive aspergillus and candida infection in immunosuppressed individuals.
Darunavir:
  • Inhibitor of HIV-I protease
  • Selectively inhibits cleavage of HIV encoded Gag-Pol polyproteins in infected cells.
Lisdexampfetamine:
  • Pro drug of dextroamfetamine
  • In Attention Deficit/Hyperactivity Disorders in the 6-12 year age group
Cyclobenzaprine:
  • Extended release formulation of skeletal muscle relaxant
  • As an adjunct to rest and physiotherapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.
Erlotinib:
  • Human Epithelial Grouth Factor type I/Epidermal Growth Factor Receptor [HER1/EGFR] inhibitor.
  • In treatment of non small cell Lung and Pancreatic cancer.

Category: Pharmacology Notes

POST COMMENT

0 comments:

Post a Comment